Use of Silodosin to Treat Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Public ClinicalTrials.gov record NCT00740779. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Double-Blind, Placebo-Controlled Investigation of Silodosin in the Treatment of Subjects With Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective is to compare the efficacy of silodosin 4 and 8 mg once daily with placebo in the treatment of subjects with moderate to severe abacterial chronic prostatitis/chronic pelvic pain syndrome during a 12 week treatment period. The secondary objective is to compare the safety of silodosin 4 and 8 mg once daily with placebo.
Study identification
- NCT ID
- NCT00740779
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 153 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2008 (Type not available)
- Primary completion
- Oct 2009 (Actual)
- Completion
- Oct 2009 (Actual)
- Last update posted
- Feb 24, 2012
2008 – 2009
United States locations
- U.S. sites
- 22
- U.S. states
- 15
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Watson Investigational Site | San Diego | California | — | — |
| Watson Investigational Site | Denver | Colorado | — | — |
| Watson Investigational Site | Columbus | Georgia | — | — |
| Watson Investigational Site | Roswell | Georgia | — | — |
| Watson Investigational Site | Jeffersonville | Indiana | — | — |
| Watson Investigational Site | West Des Moines | Iowa | — | — |
| Watson Investigational Site | Baltimore | Maryland | — | — |
| Watson Investigational Site | Boston | Massachusetts | — | — |
| Watson Investigational Site | Watertown | Massachusetts | — | — |
| Watson Investigational Site | Omaha | Nebraska | — | — |
| Watson Investigational Site | Voorhees Township | New Jersey | — | — |
| Watson Investigational Site | Albuquerque | New Mexico | — | — |
| Watson Investigational Site | Garden City | New York | — | — |
| Watson Investigational Site | Kingston | New York | — | — |
| Watson Investigational Site | New York | New York | — | — |
| Watson Investigational Site | Poughkeepsie | New York | — | — |
| Watson Investigational Site | Columbus | Ohio | — | — |
| Watson Investigational Site | Bethany | Oklahoma | — | — |
| Watson Investigational Site | Edmond | Oklahoma | — | — |
| Watson Investigational Site | State College | Pennsylvania | — | — |
| Watson Investigational Site | Mountlake Terrace | Washington | — | — |
| Watson Investigational Site | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00740779, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 24, 2012 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00740779 live on ClinicalTrials.gov.